Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
6. Global Hormonal Contraceptives Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Method (Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, Others)
6.2.2. By Hormone (Combination Hormonal Contraceptives v/s Progestin Only)
6.2.3. By Region
6.2.4. By Company (2022)
6.3. Market Map
6.3.1. By Method
6.3.2. By Hormone
6.3.3. By Region
7. North America Hormonal Contraceptives Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Method
7.2.2. By Hormone
7.2.3. By Country
7.3. North America: Country Analysis
7.3.1. United States Hormonal Contraceptives Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Method
7.3.1.2.2. By Hormone
7.3.2. Canada Hormonal Contraceptives Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Method
7.3.2.2.2. By Hormone
7.3.3. Mexico Hormonal Contraceptives Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Method
7.3.3.2.2. By Hormone
8. Europe Hormonal Contraceptives Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Method
8.2.2. By Hormone
8.2.3. By Country
8.3. Europe: Country Analysis
8.3.1. France Hormonal Contraceptives Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Method
8.3.1.2.2. By Hormone
8.3.2. Germany Hormonal Contraceptives Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Method
8.3.2.2.2. By Hormone
8.3.3. United Kingdom Hormonal Contraceptives Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Method
8.3.3.2.2. By Hormone
8.3.4. Italy Hormonal Contraceptives Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Method
8.3.4.2.2. By Hormone
8.3.5. Spain Hormonal Contraceptives Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Method
8.3.5.2.2. By Hormone
9. Asia-Pacific Hormonal Contraceptives Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Method
9.2.2. By Hormone
9.2.3. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Hormonal Contraceptives Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Method
9.3.1.2.2. By Hormone
9.3.2. India Hormonal Contraceptives Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Method
9.3.2.2.2. By Hormone
9.3.3. Japan Hormonal Contraceptives Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Method
9.3.3.2.2. By Hormone
9.3.4. South Korea Hormonal Contraceptives Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Method
9.3.4.2.2. By Hormone
9.3.5. Australia Hormonal Contraceptives Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Method
9.3.5.2.2. By Hormone
10. South America Hormonal Contraceptives Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Method
10.2.2. By Hormone
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Hormonal Contraceptives Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Method
10.3.1.2.2. By Hormone
10.3.2. Argentina Hormonal Contraceptives Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Method
10.3.2.2.2. By Hormone
10.3.3. Colombia Hormonal Contraceptives Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Method
10.3.3.2.2. By Hormone
11. Middle East and Africa Hormonal Contraceptives Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Method
11.2.2. By Hormone
11.2.3. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Hormonal Contraceptives Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Method
11.3.1.2.2. By Hormone
11.3.2. Saudi Arabia Hormonal Contraceptives Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Method
11.3.2.2.2. By Hormone
11.3.3. UAE Hormonal Contraceptives Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Method
11.3.3.2.2. By Hormone
11.3.4. Turkey Hormonal Contraceptives Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Method
11.3.4.2.2. By Hormone
11.3.5. Egypt Hormonal Contraceptives Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Method
11.3.5.2.2. By Hormone
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Launches
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. Abbvie, Inc.
14.6.2. Afaxys, Inc.
14.6.3. Teva Pharmaceuticals Industries Ltd.
14.6.4. Bayer AG
14.6.5. Merck & Co. Inc.
14.6.6. Organon Group of Companies
14.6.7. Pfizer Inc.
14.6.8. Johnson & Johnson
14.6.9. Lupin Pharmaceuticals Inc.
14.6.10. Pregna International Ltd.
15. Strategic Recommendations